SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

MaxLinears plan to enter the active electrical cable market Credo currently dominates has intensified concerns about future competition and contributed to the selloff. Traders are split between viewing the threat as serious and seeing the decline as an overreaction, arguing that rapid AI data-center demand could support growth even if Credo loses share.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas stronger-than-expected quarterly results and raised full-year outlook have fueled attention around its rally to record highs, with traders also citing demand for defensive consumer-staples stocks as tech shares weaken. Some investors question whether the run is sustainable given the stocks elevated valuation.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&Ts selloff is being tied mainly to SpaceXs reported push toward a U.S. wireless network, including plans to access cell sites, raising fears of a new competitor despite AT&T beating earnings expectations and raising its outlook. Traders disagree on whether the threat is meaningful soon or years away, with many viewing the drop as an overreaction and others warning of future pressure on carriers.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid a choppy rotation between Magnificent Seven stocks and semiconductors, with debate over whether mega-cap tech is poised to rebound or is weakening under concerns about AI spending and returns. Bulls see the pullback as a buying opportunity and point to bullish chart setups, while bears warn that leadership is faltering.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics early Phase 1 azer-cel results in progressive MS are drawing attention, with disability scores stable or improved for most evaluable patients and no severe treatment-related toxicities reported. Traders largely view the findings as promising pipeline potential, while noting the small, preliminary study and a muted share-price response; BRIUMVIs longer-term data and upcoming subcutaneous readout also feature in the discussion.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys earnings beat and raised outlook, driven by strong QNX performance, are drawing attention alongside Alloy Kores first major design win and a newly disclosed Uber selection of QNX for next-generation vehicles. Many traders see these developments and expanding QNX opportunities in automotive and physical AI as bullish, while others question why the share price has not sustained a stronger reaction and point to market pressure.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows rebound into its quarterly earnings is drawing attention, with analyst upgrades and optimism about enterprise AI adoption and AI-agent governance cited as support. Bulls view the strength as part of a recovery in software and a rotation away from chip stocks, while skeptics point to valuation, sharp reversals, and the risk of a post-earnings pullback.

Lufax Holding Ltd. operates a technology-empowered personal financial services platform. It offers personal lending and wealth management solutions. The company was founded in August 2005 and is headquartered in Shanghai, China.

Lufax Holding Ltd - ADR

Lufaxs preliminary Q3 loss warning and reverse stock split are driving bearish discussion, amid a wider selloff in Chinese fintech lenders. Some traders view tax-related charges as largely accounting-related, while others remain concerned about credit losses, regulatory uncertainty and the companys governance.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Traders are focused on CRISPR Therapeutics CTX310 Phase 1b data presentation at the AHA conference, with speculation that results could validate its in vivo gene-editing approach for cardiovascular disease. Some are positioning ahead of the readout, while others doubt the stock will break out of its long-running range even if the data are encouraging.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is caught in a choppy debate over small caps amid elevated oil prices and U.S.-Iran tensions, which traders fear could stoke inflation and complicate the Feds rate decision. Some see the pressure as bearish for small caps, while others point to their relative resilience and potential rotation into the group as yields ease.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is This the Right Time to Retain Omnicell Stock in Your Portfolio?

OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.

Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2026, before market open on Thursday, October 29, 2026. The Company will host a conference call and webcast to...

Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength?

Tempus (TEM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Here's Why Omnicell (OMCL) is a Strong Value Stock

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations PR Newswire BOSTON, Sept. 3, 2026 Integration brings serialized product verification and traceability directly...

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 12:45p.m. EDT. Live and archived webcasts of the...

Omnicell Becomes Oversold (OMCL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Omnicell President Sells 6,753 Shares

Key PointsThe disposal comprised 6,753 shares representing a total transaction value of ~$250,000...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Omnicell, Inc.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$37.75
Prev Close	$37.10
Open	$36.87
Dividend Yield	0.00%
50-Day Moving Average	$34.56
Beta	0.83
Avg. Volume	571,889.68
PE Ratio	44.64

52-Week High	$55.00
52-Week Low	$29.09
Market Capitalization	$1.72B
EPS (Annual)	$0.0443
Price to Book	1.33
Revenue Per Employee	$330,962.29

Feed

News

Sentiment

Earnings

Fundamentals

Info

OMCL Fundamentals